# OnCo record nct06007690 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06007690/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06007690", "NCT06007690" ;
  schema:name "A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma"@en ;
  schema:alternateName "CoMpass"@en ;
  schema:description "A phase 3 trial of Bel-sar in uveal melanoma, run by Aura Biosciences, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06007690/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06007690> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-12-06" ;
  onco:cancers <https://onco.cc/cancers/uveal-melanoma/> ;
  onco:companies <https://onco.cc/companies/aura-biosciences/> .